Tax
Income Tax
Vertex Pharmaceuticals Income Tax increased by 58.3% to $221.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 163.4%, from $84.10M to $221.50M. Over 4 years (FY 2021 to FY 2025), Income Tax shows an upward trend with a 15.5% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementIncome Statement
SectionTax
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
Changes may reflect shifts in corporate tax law, geographic earnings mix, or the expiration of tax incentives.
Detailed definition
The total amount of income tax a company expects to pay to federal, state, and foreign governments based on its earnings...
Peer comparison
Global companies often have complex tax expenses due to earnings in multiple international jurisdictions.
Metric ID:
income_tax_expenseHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$111.18M | $230.81M | $100.84M | $192.70M | $213.90M | $245.90M | $257.90M | $191.70M | $245.80M | $143.90M | $178.80M | $179.50M | $202.40M | $178.70M | $223.50M | $84.10M | $250.10M | $215.90M | $139.90M | $221.50M |
| QoQ Change | — | +307.6% | -56.3% | +91.1% | +11.0% | +15.0% | +4.9% | -25.7% | +28.2% | -41.5% | +24.3% | +0.4% | +12.8% | -11.7% | +25.1% | -62.4% | +197.4% | -13.7% | -35.2% | +58.3% |
| YoY Change | — | — | — | — | +292.4% | +6.5% | +155.7% | -0.5% | +14.9% | -41.5% | -30.7% | -6.4% | -17.7% | +24.2% | +25.0% | -53.1% | +23.6% | +20.8% | -37.4% | +163.4% |
Range-$111.18M – $257.90M
CAGR+15.6%
Avg YoY Growth+33.7%
Median YoY Growth+10.7%
Business Segments
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Pharmaceuticals | $84.10M | $250.10M | $215.90M | $139.90M | $221.50M |
| Total | $84.10M | $250.10M | $215.90M | $139.90M | $221.50M |
Income Tax at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's income tax?
- Vertex Pharmaceuticals (VRTX) reported income tax of $221.50M in Q1 2026.
- How has Vertex Pharmaceuticals's income tax changed year-over-year?
- Vertex Pharmaceuticals's income tax increased by 163.4% year-over-year, from $84.10M to $221.50M.
- What is the long-term trend for Vertex Pharmaceuticals's income tax?
- Over 4 years (2021 to 2025), Vertex Pharmaceuticals's income tax has grown at a 15.5% compound annual growth rate (CAGR), from $388.30M to $690.00M.
- What does income tax mean?
- The amount of money a company sets aside to pay its corporate income taxes.